4.4 Review

Recombinant DNA Technologies for Construction of Precisely Designed Transgene Constructs

期刊

CURRENT PHARMACEUTICAL BIOTECHNOLOGY
卷 10, 期 2, 页码 244-251

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920109787315033

关键词

Cloning; restriction enzyme; site-specific recombinase; Red/ET recombineering; transgene

向作者/读者索取更多资源

Genetically modified animals have been used as models in broad range of studies including pharmaceutical biology. Designing and construction of transgene constructs are the first indispensable task in generating model animals. In addition to the classical restriction enzyme-based method, still holds some advantages in generating precise constructs, site-specific recombinase-based and homologous recombination-based DNA engineering strategies ( e. g. Gateway and Red/ET recombineering, respectively) have been developed and widely used for vector construction or BAC modification. In this review, the three construction methods are described and their applications are discussed such as tandem assemblies of multiple components and modification of large DNA molecules. Combinational use of these E. coli-based recombinant DNA technologies enables the generation of precisely designed vectors useful for desired genome modification for future analyses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据